Zhizhong Pan
- Cancer Research top 1%
- Oncology top 2%
- Colorectal Cancer Surgical Treatments 57
- Colorectal Cancer Treatments and Studies 55
- Colorectal Cancer Screening and Detection 23
- Cancer Immunotherapy and Biomarkers 21
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 29
-
- Genetic factors in colorectal cancer 48
- Biological Psychiatry top 10%
-
- Colorectal and Anal Carcinomas 42
-
- Gastric Cancer Management and Outcomes 37
- Cited by
- Cancer ResearchOncologyHepatology
- Journals
- Nature Communications (2 papers)Journal of Clinical Oncology (14 papers)Gastroenterology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhizhong Pan
172 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 1.2k
- Oncology 1.3k
- Hepatology 215
- Pathology and Forensic Medicine 465
- Biological Psychiatry 52
Countries citing papers authored by Zhizhong Pan
This map shows the geographic impact of Zhizhong Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhizhong Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhizhong Pan more than expected).
Fields of papers citing papers by Zhizhong Pan
This network shows the impact of papers produced by Zhizhong Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhizhong Pan. The network helps show where Zhizhong Pan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhizhong Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 22 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 26 | |
| 8 | 2023 | 1 | |
| 9 | Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancerbreakdown → | 2023 | 240 |
| 10 | 2023 | 9 | |
| 11 | 2022 | 19 | |
| 12 | 2021 | 43 | |
| 13 | 2021 | 1 | |
| 14 | 2019 | 16 | |
| 15 | Stoma self-efficacy, hope and social relationships among patients with permanent colostomy | 2018 | 1 |
| 16 | 2018 | 4 | |
| 17 | 2016 | 0 | |
| 18 | 2015 | 7 | |
| 19 | Expression and clinical significance of high mobility group box 1 in stage IIIB colon cancer | 2011 | 1 |
| 20 | The expression and clinicobiological significance of Survivin in Dukes'C stage colorectal cancer | 2005 | 1 |
About Zhizhong Pan
Zhizhong Pan is a scholar working on Oncology, Hepatology and Pathology and Forensic Medicine, having authored 178 papers that have together received 3.1k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (57 papers), Colorectal Cancer Treatments and Studies (55 papers), Genetic factors in colorectal cancer (48 papers), Colorectal and Anal Carcinomas (42 papers), Gastric Cancer Management and Outcomes (37 papers), Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Colorectal Cancer Screening and Detection (23 papers) and Cancer Immunotherapy and Biomarkers (21 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.3k citations) and Hepatology (215 citations). Zhizhong Pan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jianhong Peng, Zhenhai Lu, Xiaojun Wu, Junzhong Lin, Rui‐Hua Xu, Peirong Ding, Ranyi Liu, Desen Wan, Yujing Fang and Wenlin Huang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.